Autopsy report · NCT05175768
Study to Evaluate the Effect of Nicotinamide Mononucleotide (NMN) As an Adjuvant to Standard of Care (SOC) On Fatigue Associated With COVID-19 Infection
Cause of deathStaffing, sites or logistics
“Required criteria of covid patient was not met”
Life of this trial
- Ran for about 7 months before it stopped.
- 69 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Vedic Lifesciences Pvt. Ltd.
- Sponsor type
- Industry
- Conditions
- COVID-19 Infection
- Interventions
- Nicotinamide Mononucleotide; Nicotinamide Mononucleotide with L-Leucine; Placebo
- Participants
- 69
- Sites
- 12
- Countries
- India
Trials that died the same way
- Feasibility of a Self-guided Exercise Program Among Hospitalized COVID-19 Patients
“COVID patients admitted to the hospital during the study dates did NOT have the criteria to enter the study(i.e they were too medically unstable) or their hospital stay was too short to conduct a before and after assessment” - Transgender Therapeutic Support Groups
“Study unable to be conducted due to COVID.” - Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID)
“study protocol was changed to include non-COVID patients and registered under a different ID” - Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection
“lack of Covid-19 patients” - Physio PCI: Impact of Coronary Angioplasty on Non-hyperaemic Pressure Ratio in Patients With Coronary Artery Disease
“Due to COVID-19 pandemic site refused to include patients in the study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.